{"id":"W2065301637","doi":"10.1016/j.eplepsyres.2012.05.007","title":"Safety and efficacy of ezogabine (retigabine) in adults with refractory partial-onset seizures: Interim results from two ongoing open-label studies","year":2012,"lang":"en","type":"article","venue":"Epilepsy Research","topic":"Epilepsy research and treatment","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":false,"ca_institutions":"","funders":"Valeant Pharmaceuticals International; GlaxoSmithKline","keywords":"Tolerability; Medicine; Open label; Somnolence; Anesthesia; Refractory (planetary science); Epilepsy; Anticonvulsant; Adverse effect; Internal medicine","routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003704962,0.0009546612,0.002829852,0.0003270553,0.0003961055,0.0008365154,0.0006704783,0.001620237,0.001652753],"category_scores_gemma":[0.003356365,0.0003041438,0.00189661,0.000408892,0.0009477979,0.001592404,0.0002779493,0.002223715,0.0005386832],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007401331,"about_ca_system_score_gemma":0.0008725338,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000866767,"about_ca_topic_score_gemma":0.00152158,"domain_scores_codex":[0.9990101,0.0004763615,0.0001387544,0.0001090394,0.0001159287,0.0001498616],"domain_scores_gemma":[0.9975364,0.001047071,0.0005895078,0.0003109206,0.0002171629,0.000298937],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.7653053,0.01052673,0.01274097,0.001091535,0.003175863,0.0004202148,0.0003573558,0.0009189366,0.01992016,0.0002226198,0.00184703,0.1834733],"study_design_scores_gemma":[0.4848644,0.40427,0.07963302,0.000207261,0.005468323,0.001255333,0.0002958323,0.001338509,0.01390126,0.0007341743,0.007926815,0.0001051776],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9869568,0.008160167,0.0009034291,0.0005763597,0.00007997254,0.0005894512,0.001424393,0.00007128116,0.001238061],"genre_scores_gemma":[0.9901993,0.003378027,0.001526966,0.0009106352,0.0001663571,0.0005452009,0.002363014,0.00002134051,0.0008892588],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003704962,"threshold_uncertainty_score":0.01959395,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.136092806450146,"score_gpt":0.4441202531045085,"score_spread":0.3080274466543625,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}